P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
P07900 |
HS90A_HUMAN |
Acute upper respiratory infection [ICD-11: CA07] |
P07900 |
HS90A_HUMAN |
Asthma [ICD-11: CA23] |
P07900 |
HS90A_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P07900 |
HS90A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P07900 |
HS90A_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P07900 |
HS90A_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P07900 |
HS90A_HUMAN |
Lung cancer [ICD-11: 2C25] |
P07900 |
HS90A_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P07900 |
HS90A_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P07900 |
HS90A_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P07900 |
HS90A_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P07900 |
HS90A_HUMAN |
Encephalopathy [ICD-11: 8E47] |
P07900 |
HS90A_HUMAN |
Mature B-cell lymphoma [ICD-11: 2A85] |
P07900 |
HS90A_HUMAN |
Melanoma [ICD-11: 2C30] |
P07900 |
HS90A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P07900 |
HS90A_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P07900 |
HS90A_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P07900 |
HS90A_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P07900 |
HS90A_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
P84022 |
SMAD3_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P84022 |
SMAD3_HUMAN |
Kidney fibrosis [ICD-11: GC01] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P37840 |
SYUA_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P37840 |
SYUA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P37840 |
SYUA_HUMAN |
Autonomic nervous system disorder [ICD-11: 8D87] |
Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P05412 |
JUN_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05412 |
JUN_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
Q99814 |
EPAS1_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q99814 |
EPAS1_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
Q99814 |
EPAS1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q99814 |
EPAS1_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q99814 |
EPAS1_HUMAN |
Adrenomedullary hyperfunction [ICD-11: 5A75] |
Q99814 |
EPAS1_HUMAN |
Brain cancer [ICD-11: 2A00] |
Q99814 |
EPAS1_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P01106 |
MYC_HUMAN |
Coronary atherosclerosis [ICD-11: BA80] |
P01106 |
MYC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |